{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T14:43:28Z","timestamp":1776609808933,"version":"3.51.2"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T00:00:00Z","timestamp":1400544000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s12640-014-9477-9","type":"journal-article","created":{"date-parts":[[2014,5,19]],"date-time":"2014-05-19T14:48:13Z","timestamp":1400510893000},"page":"255-273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Lack of Neuroprotective Effect of Celastrol Under Conditions of Proteasome Inhibition by Lactacystin in In Vitro and In Vivo Studies: Implications for Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"26","author":[{"given":"Jolanta","family":"Konieczny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danuta","family":"Jantas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Lenda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Domin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Czarnecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Kuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"\u015amia\u0142owska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W\u0142adys\u0142aw","family":"Laso\u0144","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Lorenc-Koci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,20]]},"reference":[{"key":"9477_CR1","first-page":"2615","volume":"59","author":"J Adams","year":"1999","unstructured":"Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD, Maas J, Pien CS, Prakash S, Elliott PJ (1999) Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res 59:2615\u20132622","journal-title":"Cancer Res"},{"key":"9477_CR2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.brainres.2006.02.097","volume":"1087","author":"TB Ahn","year":"2006","unstructured":"Ahn TB, Jeon BS (2006) Protective role of heat shock and heat shock protein 70 in lactacystin-induced cell death both in the rat substantia nigra and PC12 cells. Brain Res 1087:159\u2013167","journal-title":"Brain Res"},{"key":"9477_CR3","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0278-5846(01)00192-0","volume":"25","author":"AC Allison","year":"2001","unstructured":"Allison AC, Cacabelos R, Lombardi VR, Alvarez XA, Vigo C (2001) Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry 25:1341\u20131357","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9477_CR4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.leu.2402417","volume":"16","author":"JB Almond","year":"2002","unstructured":"Almond JB, Cohen GM (2002) The proteasome: a novel target for cancer chemotherapy. Leukemia 16:433\u2013443","journal-title":"Leukemia"},{"key":"9477_CR5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","volume":"299","author":"V Bonifati","year":"2003","unstructured":"Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MC, Squitieri F, Ibanez P, Joosse M, van Dongen JW, Vanacore N, van Swieten JC, Brice A, Meco G, van Duijn CM, Oostra BA, Heutink P (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299:256\u2013259","journal-title":"Science"},{"key":"9477_CR6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, R\u00fcb U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 318:121\u2013134","journal-title":"Cell Tissue Res"},{"key":"9477_CR7","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/jnr.490420510","volume":"42","author":"GJ Brewer","year":"1995","unstructured":"Brewer GJ (1995) Serum-free B27\/neurobasal medium supports differentiated growth of neurones from the striatum, substantia nigra, septum, cerebral cortex, cerebellum and dentate gyrus. J Neurosci Res 42:674\u2013683","journal-title":"J Neurosci Res"},{"key":"9477_CR8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neuint.2012.10.014","volume":"62","author":"B Cheng","year":"2013","unstructured":"Cheng B, Martinez AA, Morado J, Scofield V, Roberts JL, Maffi SK (2013) Retinoic acid protects against proteasome inhibition associated cell death in SH-SY5Y cells via the AKT pathway. Neurochem Int 62:31\u201342","journal-title":"Neurochem Int"},{"key":"9477_CR9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1379\/CSC-269.1","volume":"12","author":"AM Chow","year":"2007","unstructured":"Chow AM, Brown IR (2007) Induction of heat shock proteins in differentiated human and rodent neurons by celastrol. Cell Stress Chaperones 12:237\u2013244","journal-title":"Cell Stress Chaperones"},{"key":"9477_CR10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0896-6273(03)00606-8","volume":"40","author":"A Ciechanover","year":"2003","unstructured":"Ciechanover A, Brundin P (2003) The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40:427\u2013446","journal-title":"Neuron"},{"key":"9477_CR11","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1471-4159.2005.03253.x","volume":"94","author":"C Cleren","year":"2005","unstructured":"Cleren C, Calingasan NY, Chen J, Beal MF (2005) Celastrol protects against MPTP- and 3-nitropropionic acid-induced neurotoxicity. J Neurochem 94:995\u20131004","journal-title":"J Neurochem"},{"key":"9477_CR12","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39:889\u2013909","journal-title":"Neuron"},{"key":"9477_CR13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0300-9084(01)01250-0","volume":"83","author":"KJ Davies","year":"2001","unstructured":"Davies KJ (2001) Degradation of oxidized proteins by the 20S proteasome. Biochimie 83:301\u2013310","journal-title":"Biochimie"},{"key":"9477_CR14","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","volume":"38","author":"H Ehringer","year":"1960","unstructured":"Ehringer H, Hornykiewicz O (1960) Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Klin Wochenschr 38:1236\u20131239","journal-title":"Klin Wochenschr"},{"key":"9477_CR15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1023\/A:1015160323009","volume":"21","author":"H Elkon","year":"2001","unstructured":"Elkon H, Melamed E, Offen D (2001) 6-Hydroxydopamine increases ubiquitin-conjugates and protein degradation: implications for the pathogenesis of Parkinson\u2019s disease. Cell Mol Neurobiol 21:771\u2013781","journal-title":"Cell Mol Neurobiol"},{"key":"9477_CR16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1385\/JMN:24:3:387","volume":"24","author":"H Elkon","year":"2004","unstructured":"Elkon H, Melamed E, Offen D (2004) Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: implications for the pathogenesis of Parkinson\u2019s disease. J Mol Neurosci 24:387\u2013400","journal-title":"J Mol Neurosci"},{"key":"9477_CR17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1471-2202-10-109","volume":"10","author":"K Faust","year":"2009","unstructured":"Faust K, Gehrke S, Yang Y, Yang L, Beal MF, Lu B (2009) Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson\u2019s disease. BMC Neurosci 10:109","journal-title":"BMC Neurosci"},{"key":"9477_CR18","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.7732382","volume":"268","author":"G Fenteany","year":"1995","unstructured":"Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, Schreiber SL (1995) Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726\u2013731","journal-title":"Science"},{"key":"9477_CR19","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1523\/JNEUROSCI.23-26-08955.2003","volume":"23","author":"F Fornai","year":"2003","unstructured":"Fornai F, Lenzi P, Gesi M, Ferrucci M, Lazzeri G, Busceti CL, Ruffoli R, Soldani P, Ruggieri S, Alessandri MG, Paparelli A (2003) Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition. J Neurosci 23:8955\u20138966","journal-title":"J Neurosci"},{"key":"9477_CR20","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1073\/pnas.0409713102","volume":"102","author":"F Fornai","year":"2005","unstructured":"Fornai F, Schl\u00fcter OM, Lenzi P, Gesi M, Ruffoli R, Ferrucci M, Lazzeri G, Busceti CL, Pontarelli F, Battaglia G, Pellegrini A, Nicoletti F, Ruggieri S, Paparelli A, S\u00fcdhof TC (2005) Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci USA 102:3413\u20133418","journal-title":"Proc Natl Acad Sci USA"},{"key":"9477_CR21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2818.1999.00457.x","volume":"193","author":"HJ Gundersen","year":"1999","unstructured":"Gundersen HJ, Jensen EB, Kie\u02c6u K, Nielsen J (1999) The efficiency of systematic sampling in stereology \u2013 reconsidered. J Microsc 193:199\u2013211","journal-title":"J Microsc"},{"key":"9477_CR22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neuint.2003.11.018","volume":"45","author":"A Hermida-Ameijeiras","year":"2004","unstructured":"Hermida-Ameijeiras A, M\u00e9ndez-Alvarez E, S\u00e1nchez-Iglesias S, Sanmart\u00edn-Su\u00e1rez C, Soto-Otero R (2004) Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions. Neurochem Int 45:103\u2013116","journal-title":"Neurochem Int"},{"key":"9477_CR23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol 8:382\u2013397","journal-title":"Lancet Neurol"},{"key":"9477_CR24","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1046\/j.1471-4159.2003.01952.x","volume":"86","author":"GU H\u00f6glinger","year":"2003","unstructured":"H\u00f6glinger GU, Carrard G, Michel PP, Medja F, Lomb\u00e8s A, Ruberg M, Friguet B, Hirsch EC (2003) Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson\u2019s disease. J Neurochem 86:1297\u20131307","journal-title":"J Neurochem"},{"key":"9477_CR25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1254\/jphs.FP0040525","volume":"97","author":"M Inden","year":"2005","unstructured":"Inden M, Kondo J, Kitamura Y, Takata K, Nishimura K, Taniguchi T, Sawada H, Shimohama S (2005) Proteasome inhibitors protect against degeneration of nigral dopaminergic neurons in hemiparkinsonian rats. J Pharmacol Sci 97:203\u2013211","journal-title":"J Pharmacol Sci"},{"key":"9477_CR26","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.neuro.2011.05.013","volume":"32","author":"D Jantas","year":"2011","unstructured":"Jantas D, Lorenc-Koci E, Kubera M, Lason W (2011) Neuroprotective effects of MAPK\/ERK1\/2 and calpain inhibitors on lactacystin-induced cell damage in primary cortical neurons. Neurotoxicology 32:845\u2013856","journal-title":"Neurotoxicology"},{"key":"9477_CR27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12640-012-9374-z","volume":"24","author":"D Jantas","year":"2013","unstructured":"Jantas D, Roman A, Ku\u015bmierczyk J, Lorenc-Koci E, Konieczny J, Lenda T, Laso\u0144 W (2013) The extent of neurodegeneration and neuroprotection in two chemical in vitro models related to Parkinson\u2019s disease is critically dependent on cell culture conditions. Neurotox Res 24:41\u201354","journal-title":"Neurotox Res"},{"key":"9477_CR28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.brainres.2005.11.055","volume":"1069","author":"D Jantas-Skotniczna","year":"2006","unstructured":"Jantas-Skotniczna D, Kajta M, Lason W (2006) Memantine attenuates staurosporine-induced activation of caspase-3 and LDH release in mouse primary neuronal cultures. Brain Res 1069:145\u2013153","journal-title":"Brain Res"},{"issue":"Suppl 1","key":"9477_CR29","first-page":"24","volume":"13","author":"P Jenner","year":"1998","unstructured":"Jenner P (1998) Oxidative mechanisms in nigral cell death in Parkinson\u2019s disease. Mov Disord 13(Suppl 1):24\u201334","journal-title":"Mov Disord"},{"issue":"Suppl 3","key":"9477_CR30","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","volume":"53","author":"P Jenner","year":"2003","unstructured":"Jenner P (2003) Oxidative stress in Parkinson\u2019s disease. Ann Neurol 53(Suppl 3):S26\u2013S36 discussion S36-S38","journal-title":"Ann Neurol"},{"key":"9477_CR31","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s10571-008-9271-4","volume":"28","author":"N Kadoguchi","year":"2008","unstructured":"Kadoguchi N, Umeda M, Kato H, Araki T (2008) Proteasome inhibitor does not enhance MPTP neurotoxicity in mice. Cell Mol Neurobiol 28:971\u2013979","journal-title":"Cell Mol Neurobiol"},{"key":"9477_CR32","doi-asserted-by":"crossref","unstructured":"Kannaiyan R, Shanmugam MK, Sethi G (2011) Molecular targets of celastrol derived from Thunder of God Vine: potential role in the treatment of inflammatory disorders and cancer. Cancer Lett 303:9\u201320","DOI":"10.1016\/j.canlet.2010.10.025"},{"key":"9477_CR33","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000090364","volume":"2","author":"M Kiaei","year":"2005","unstructured":"Kiaei M, Kipiani K, Petri S, Chen J, Calingasan NY, Beal MF (2005) Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis. Neurodegener Dis 2:246\u2013254","journal-title":"Neurodegener Dis"},{"key":"9477_CR34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejphar.2009.03.078","volume":"612","author":"DY Kim","year":"2009","unstructured":"Kim DY, Park JW, Jeoung D, Ro JY (2009) Celastrol suppresses allergen-induced airway inflammation in a mouse allergic asthma model. Eur J Pharmacol 612:98\u2013105","journal-title":"Eur J Pharmacol"},{"key":"9477_CR35","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605\u2013608","journal-title":"Nature"},{"key":"9477_CR36","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2008.02.030","volume":"1205","author":"SJ Kwon","year":"2008","unstructured":"Kwon SJ, Ahn TB, Yoon MY, Jeon BS (2008) BV-2 stimulation by lactacystin results in a strong inflammatory reaction and apoptotic neuronal death in SH-SY5Y cells. Brain Res 1205:116\u2013121","journal-title":"Brain Res"},{"key":"9477_CR37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1471-4159.2001.00416.x","volume":"78","author":"MH Lee","year":"2001","unstructured":"Lee MH, Hyun DH, Jenner P, Halliwell B (2001) Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production. J Neurochem 78:32\u201341","journal-title":"J Neurochem"},{"key":"9477_CR38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/26652","volume":"395","author":"E Leroy","year":"1998","unstructured":"Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, Harta G, Brownstein MJ, Jonnalagada S, Chernova T, Dehejia A, Lavedan C, Gasser T, Steinbach PJ, Wilkinson KD, Polymeropoulos MH (1998) The ubiquitin pathway in Parkinson\u2019s disease. Nature 395:451\u2013452","journal-title":"Nature"},{"key":"9477_CR39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/neu.10037","volume":"51","author":"C Lesuisse","year":"2002","unstructured":"Lesuisse C, Martin LJ (2002) Long-term culture of mouse cortical neurons as a model for neuronal development, aging, and death. J Neurobiol 51:9\u201323","journal-title":"J Neurobiol"},{"key":"9477_CR40","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jep.2008.05.028","volume":"118","author":"H Li","year":"2008","unstructured":"Li H, Zhang YY, Tan HW, Jia YF, Li D (2008a) Therapeutic effect of tripterine on adjuvant arthritis in rats. J Ethnopharmacol 118:479\u2013484","journal-title":"J Ethnopharmacol"},{"key":"9477_CR41","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/NEN.0b013e318186de64","volume":"67","author":"X Li","year":"2008","unstructured":"Li X, Du Y, Fan X, Yang D, Luo G, Le W (2008b) c-Jun N-terminal kinase mediates lactacystin-induced dopamine neuron degeneration. J Neuropathol Exp Neurol 67:933\u2013944","journal-title":"J Neuropathol Exp Neurol"},{"key":"9477_CR42","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1007\/s11064-010-0214-3","volume":"35","author":"C Li","year":"2010","unstructured":"Li C, Guo Y, Xie W, Li X, Janokovic J, Le W (2010) Neuroprotection of pramipexole in UPS impairment induced animal model of Parkinson\u2019s disease. Neurochem Res 35:1546\u20131556","journal-title":"Neurochem Res"},{"key":"9477_CR43","doi-asserted-by":"crossref","first-page":"e68905","DOI":"10.1371\/journal.pone.0068905","volume":"8","author":"G Li","year":"2013","unstructured":"Li G, Liu D, Zhang Y, Qian Y, Zhang H, Guo S, Sunagawa M, Hisamitsu T, Liu Y (2013) Celastrol inhibits lipopolysaccharide-stimulated rheumatoid fibroblast-like synoviocyte invasion through suppression of TLR4\/NF-\u03baB-mediated matrix metalloproteinase-9 expression. PLoS ONE 8:e68905","journal-title":"PLoS ONE"},{"key":"9477_CR44","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuint.2011.03.013","volume":"58","author":"E Lorenc-Koci","year":"2011","unstructured":"Lorenc-Koci E, Lenda T, Antkiewicz-Michaluk L, Wardas J, Domin H, \u015amia\u0142owska M, Konieczny J (2011) Different effects of intranigral and intrastriatal administration of the proteasome inhibitor lactacystin on typical neurochemical and histological markers of Parkinson\u2019s disease in rats. Neurochem Int 58:839\u2013849","journal-title":"Neurochem Int"},{"key":"9477_CR45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.expneurol.2013.03.021","volume":"247","author":"S Mackey","year":"2013","unstructured":"Mackey S, Jing Y, Flores J, Dinelle K, Doudet DJ (2013) Direct intranigral administration of an ubiquitin proteasome system inhibitor in rat: Behavior, positron emission tomography, immunohistochemistry. Exp Neurol 247:19\u201324","journal-title":"Exp Neurol"},{"key":"9477_CR46","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.bcp.2008.02.008","volume":"75","author":"P Maher","year":"2008","unstructured":"Maher P (2008) Proteasome inhibitors prevent oxidative stress-induced nerve cell death by a novel mechanism. Biochem Pharmacol 75:1994\u20132006","journal-title":"Biochem Pharmacol"},{"key":"9477_CR47","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.410240415","volume":"24","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Akiyama H, McGeer EG (1988) Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol 24:574\u2013576","journal-title":"Ann Neurol"},{"key":"9477_CR48","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","volume":"297","author":"KS McNaught","year":"2001","unstructured":"McNaught KS, Jenner P (2001) Proteasomal function is impaired in substantia nigra in Parkinson\u2019s disease. Neurosci Lett 297:191\u2013194","journal-title":"Neurosci Lett"},{"key":"9477_CR49","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/00001756-200208070-00018","volume":"13","author":"KS McNaught","year":"2002","unstructured":"McNaught KS, Bj\u00f6rklund LM, Belizaire R, Isacson O, Jenner P, Olanow CW (2002a) Proteasome inhibition causes nigral degeneration with inclusion bodies in rats. NeuroReport 13:1437\u20131441","journal-title":"NeuroReport"},{"key":"9477_CR50","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1471-4159.2002.00821.x","volume":"81","author":"KS McNaught","year":"2002","unstructured":"McNaught KS, Mytilineou C, Jnobaptiste R, Yabut J, Shashidharan P, Jennert P, Olanow CW (2002b) Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures. J Neurochem 81:301\u2013306","journal-title":"J Neurochem"},{"key":"9477_CR51","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/exnr.2002.8050","volume":"179","author":"KS McNaught","year":"2003","unstructured":"McNaught KS, Belizaire R, Isacson O, Jenner P, Olanow CW (2003) Altered proteasomal function in sporadic Parkinson\u2019s disease. Exp Neurol 179:38\u201346","journal-title":"Exp Neurol"},{"key":"9477_CR52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ana.20186","volume":"56","author":"KS McNaught","year":"2004","unstructured":"McNaught KS, Perl DP, Brownell AL, Olanow CW (2004) Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson\u2019s disease. Ann Neurol 56:149\u2013162","journal-title":"Ann Neurol"},{"key":"9477_CR53","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0891-5849(96)00033-0","volume":"21","author":"JW Miller","year":"1996","unstructured":"Miller JW, Selhub J, Joseph JA (1996) Oxidative damage caused by free radicals produced during catecholamine autoxidation: protective effects of O-methylation and melatonin. Free Radic Biol Med 21:241\u2013249","journal-title":"Free Radic Biol Med"},{"key":"9477_CR54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000202972","volume":"87","author":"C Niu","year":"2009","unstructured":"Niu C, Mei J, Pan Q, Fu X (2009) Nigral degeneration with inclusion body formation and behavioral changes in rats after proteasomal inhibition. Stereotact Funct Neurosurg 87:69\u201381","journal-title":"Stereotact Funct Neurosurg"},{"key":"9477_CR55","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10571-009-9402-6","volume":"29","author":"T Oshikawa","year":"2009","unstructured":"Oshikawa T, Kuroiwa H, Yano R, Yokoyama H, Kadoguchi N, Kato H, Araki T (2009) Systemic administration of proteasome inhibitor protects against MPTP neurotoxicity in mice. Cell Mol Neurobiol 29:769\u2013777","journal-title":"Cell Mol Neurobiol"},{"key":"9477_CR56","first-page":"25","volume":"592","author":"S P\u00e5hlman","year":"1990","unstructured":"P\u00e5hlman S, Mamaeva S, Meyerson G, Mattsson ME, Bjelfman C, Ortoft E, Hammerling U (1990) Human neuroblastoma cells in culture: a model for neuronal cell differentiation and function. Acta Physiol Scand Suppl 592:25\u201337","journal-title":"Acta Physiol Scand Suppl"},{"key":"9477_CR57","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s11055-013-9744-x","volume":"43","author":"IuF Pastukhov","year":"2013","unstructured":"Pastukhov IuF, Ekimova IV, Guzhova IV, Romanova IV, Artiukhina ZE (2013) Chaperone Hsp70 Content in Dopaminergic Neurons of the Substantia Nigra Increases in Proteasome Dysfunction. Neurosci Behav Physiol 43:380\u2013387","journal-title":"Neurosci Behav Physiol"},{"key":"9477_CR58","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"1986","unstructured":"Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, San Diego"},{"key":"9477_CR59","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00702-010-0428-1","volume":"117","author":"L Qian","year":"2010","unstructured":"Qian L, Flood PM, Hong JS (2010) Neuroinflammation is a key player in Parkinson\u2019s disease and a prime target for therapy. J Neural Transm 117:971\u2013979","journal-title":"J Neural Transm"},{"key":"9477_CR60","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1523\/JNEUROSCI.20-01-00259.2000","volume":"20","author":"JH Qiu","year":"2000","unstructured":"Qiu JH, Asai A, Chi S, Saito N, Hamada H, Kirino T (2000) Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons. J Neurosci 20:259\u2013265","journal-title":"J Neurosci"},{"key":"9477_CR61","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4161\/cbt.11.2.13959","volume":"11","author":"SM Raja","year":"2011","unstructured":"Raja SM, Clubb RJ, Ortega-Cava C, Williams SH, Bailey TA, Duan L, Zhao X, Reddi AL, Nyong AM, Natarajan A, Band V, Band H (2011) Anticancer activity of Celastrol in combination with ErbB2-targeted therapeutics for treatment of ErbB2-overexpressing breast cancers. Cancer Biol Ther 11:263\u2013276","journal-title":"Cancer Biol Ther"},{"key":"9477_CR62","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.expneurol.2006.07.010","volume":"202","author":"SH Reaney","year":"2006","unstructured":"Reaney SH, Johnston LC, Langston WJ, Di Monte DA (2006) Comparison of the neurotoxic effects of proteasomal inhibitors in primary mesencephalic cultures. Exp Neurol 202:434\u2013440","journal-title":"Exp Neurol"},{"key":"9477_CR63","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1471-4159.2001.00474.x","volume":"78","author":"HJ Rideout","year":"2001","unstructured":"Rideout HJ, Larsen KE, Sulzer D, Stefanis L (2001) Proteasomal inhibition leads to formation of ubiquitin\/alpha-synuclein-immunoreactive inclusions in PC12 cells. J Neurochem 78:899\u2013908","journal-title":"J Neurochem"},{"key":"9477_CR64","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/0006-291X(90)90759-G","volume":"172","author":"H Sassa","year":"1990","unstructured":"Sassa H, Takaishi Y, Terada H (1990) The triterpene celastrol as a very potent inhibitor of lipid peroxidation in mitochondria. Biochem Biophys Res Commun 172:890\u2013897","journal-title":"Biochem Biophys Res Commun"},{"key":"9477_CR65","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2818.1984.tb02501.x","volume":"134","author":"DC Sterio","year":"1984","unstructured":"Sterio DC (1984) The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc 134:127\u2013136","journal-title":"J Microsc"},{"key":"9477_CR66","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1016\/j.bmcl.2010.05.066","volume":"20","author":"H Sun","year":"2010","unstructured":"Sun H, Xu L, Yu P, Jiang J, Zhang G, Wang Y (2010) Synthesis and preliminary evaluation of neuroprotection of celastrol analogues in PC12 cells. Bioorg Med Chem Lett 20:3844\u20133847","journal-title":"Bioorg Med Chem Lett"},{"key":"9477_CR67","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbrc.2004.05.187","volume":"320","author":"K Takahashi-Niki","year":"2004","unstructured":"Takahashi-Niki K, Niki T, Taira T, Iguchi-Ariga SM, Ariga H (2004) Reduced anti-oxidative stress activities of DJ-1 mutants found in Parkinson\u2019s disease patients. Biochem Biophys Res Commun 320:389\u2013397","journal-title":"Biochem Biophys Res Commun"},{"key":"9477_CR68","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1471-4159.2004.02915.x","volume":"92","author":"K Leyen van","year":"2005","unstructured":"van Leyen K, Siddiq A, Ratan RR, Lo EH (2005) Proteasome inhibition protects HT22 neuronal cells from oxidative glutamate toxicity. J Neurochem 92:824\u2013830","journal-title":"J Neurochem"},{"issue":"2","key":"9477_CR69","doi-asserted-by":"crossref","first-page":"e17269","DOI":"10.1371\/journal.pone.0017269","volume":"6","author":"AC Vernon","year":"2011","unstructured":"Vernon AC, Crum WR, Johansson SM, Modo M (2011) Evolution of extra-nigral damage predicts behavioural deficits in a rat proteasome inhibitor model of Parkinson\u2019s disease. PLoS ONE 6(2):e17269","journal-title":"PLoS ONE"},{"key":"9477_CR70","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cbpa.2010.02.015","volume":"156","author":"SE Walcott","year":"2010","unstructured":"Walcott SE, Heikkila JJ (2010) Celastrol can inhibit proteasome activity and upregulate the expression of heat shock protein genes, hsp30 and hsp70, in Xenopus laevis A6 cells. Comp Biochem Physiol A 156:285\u2013293","journal-title":"Comp Biochem Physiol A"},{"key":"9477_CR71","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1471-4159.2012.07734.x","volume":"121","author":"X Wang","year":"2012","unstructured":"Wang X, Petrie TG, Liu Y, Liu J, Fujioka H, Zhu X (2012) Parkinson\u2019s disease-associated DJ-1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction. J Neurochem 121:830\u2013839","journal-title":"J Neurochem"},{"key":"9477_CR72","first-page":"1086","volume":"123","author":"HR Xie","year":"2010","unstructured":"Xie HR, Hu LS, Li GY (2010a) SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson\u2019s disease. Chin Med J (Engl) 123:1086\u20131092","journal-title":"Chin Med J (Engl)"},{"key":"9477_CR73","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1471-4159.2010.06914.x","volume":"115","author":"W Xie","year":"2010","unstructured":"Xie W, Li X, Li C, Zhu W, Jankovic J, Le W (2010b) Proteasome inhibition modeling nigral neuron degeneration in Parkinson\u2019s disease. J Neurochem 115:188\u2013199","journal-title":"J Neurochem"},{"key":"9477_CR74","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1074\/jbc.M603712200","volume":"282","author":"N Yamamoto","year":"2007","unstructured":"Yamamoto N, Sawada H, Izumi Y, Kume T, Katsuki H, Shimohama S, Akaike A (2007) Proteasome inhibition induces glutathione synthesis and protects cells from oxidative stress: relevance to Parkinson disease. J Biol Chem 282:4364\u20134372","journal-title":"J Biol Chem"},{"key":"9477_CR75","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1158\/0008-5472.CAN-05-4529","volume":"66","author":"H Yang","year":"2006","unstructured":"Yang H, Chen D, Cui QC, Yuan X, Dou QP (2006) Celastrol, a triterpene extracted from the Chinese \u201cThunder of God Vine,\u201d is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res 66:4758\u20134765","journal-title":"Cancer Res"},{"key":"9477_CR76","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1093\/hmg\/ddm249","volume":"16","author":"W Yang","year":"2007","unstructured":"Yang W, Chen L, Ding Y, Zhuang X, Kang UJ (2007) Paraquat induces dopaminergic dysfunction and proteasome impairment in DJ-1-deficient mice. Hum Mol Genet 16:2900\u20132910","journal-title":"Hum Mol Genet"},{"key":"9477_CR77","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2174\/157016310791162785","volume":"7","author":"H Yang","year":"2010","unstructured":"Yang H, Liu J, Dou QP (2010) Targeting tumor proteasome with traditional Chinese medicine. Curr Drug Discov Technol 7:46\u201353","journal-title":"Curr Drug Discov Technol"},{"key":"9477_CR78","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-1-4615-0123-7_10","volume":"513","author":"MA Yenari","year":"2002","unstructured":"Yenari MA (2002) Heat shock proteins and neuroprotection. Adv Exp Med Biol 513:281\u2013299","journal-title":"Adv Exp Med Biol"},{"key":"9477_CR79","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1471-4159.2005.03220.x","volume":"94","author":"EH Yew","year":"2005","unstructured":"Yew EH, Cheung NS, Choy MS, Qi RZ, Lee AY, Peng ZF, Melendez AJ, Manikandan J, Koay ES, Chiu LL, Ng WL, Whiteman M, Kandiah J, Halliwell B (2005) Proteasome inhibition by lactacystin in primary neuronal cells induces both potentially neuroprotective and pro-apoptotic transcriptional responses: a microarray analysis. J Neurochem 94:943\u2013956","journal-title":"J Neurochem"},{"key":"9477_CR80","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00109-007-0251-9","volume":"85","author":"YQ Zhang","year":"2007","unstructured":"Zhang YQ, Sarge KD (2007) Celastrol inhibits polyglutamine aggregation and toxicity though induction of the heat shock response. J Mol Med (Berl) 85:1421\u20131428","journal-title":"J Mol Med (Berl)"},{"issue":"Suppl 2","key":"9477_CR81","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1590\/S0074-02761991000600049","volume":"86","author":"BN Zhou","year":"1991","unstructured":"Zhou BN (1991) Some progress on the chemistry of natural bioactive terpenoids from Chinese medicinal plants. Mem Inst Oswaldo Cruz 86(Suppl 2):219\u2013226","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"9477_CR82","first-page":"21","volume":"17","author":"XM Zhu","year":"1996","unstructured":"Zhu XM, Xiong RC, Zhang YF, Zhang YK (1996) Studies on immunosuppresive effect of tripterine monomer on renal transplant mongrel dogs. Chin J Organ Transplant 17:21\u201322","journal-title":"Chin J Organ Transplant"},{"key":"9477_CR83","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1096\/fj.07-8386com","volume":"21","author":"W Zhu","year":"2007","unstructured":"Zhu W, Xie W, Pan T, Xu P, Fridkin M, Zheng H, Jankovic J, Youdim MB, Le W (2007) Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators. FASEB J 21:3835\u20133844","journal-title":"FASEB J"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-014-9477-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-014-9477-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-014-9477-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T15:57:31Z","timestamp":1565452651000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-014-9477-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,20]]},"references-count":83,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["9477"],"URL":"https:\/\/doi.org\/10.1007\/s12640-014-9477-9","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,20]]}}}